Vimarsana
Biggest News Aggregation in the World

Page 2 - Startengine Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Startengine Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Startengine Capital Today - Breaking & Trending Today

Mexigin® Spiced Gin Announces First Regulation Crowdfunding on StartEngine - Vimarsana News

Mexigin® Spiced Gin Announces First Regulation Crowdfunding on StartEngine

/PRNewswire/ -- Mexigin®, the world's first dark spiced gin, announced they have been selected by StartEngine Capital LLC to kick off their first Regulation...

Keeping Up With FINRA: June 2022 Facts and Trends - Vimarsana News

Keeping Up With FINRA: June 2022 Facts and Trends

FINRA enforcement arm policed crowdfunding misconduct, trading volume overstatements. Recent managed options trading strategy arbitrations continue. FINRA followed through initiatives on restricted firm designations, complex products, broker-dealer complaint expungement.

FINRA Facts and Trends: June 2022 | Bracewell LLP - Vimarsana News

FINRA Facts and Trends: June 2022 | Bracewell LLP

Welcome to the latest issue of Bracewell’s FINRA Facts and Trends, a monthly newsletter devoted to condensing and digesting recent FINRA developments in the areas of enforcement,...

Four Lessons from Two FINRA Enforcement Actions against Crowdfunding Portals | Goodwin - Vimarsana News

Four Lessons from Two FINRA Enforcement Actions against Crowdfunding Portals | Goodwin

On May 4, 2022, FINRA announced that it had fined two FINRA-registered funding portals a combined $1.75 million for failing to comply with securities laws and rules designed to protect...

World-Renowned Patient Advocate Joins SmartTab Drug Delivery Webinar - Vimarsana News

World-Renowned Patient Advocate Joins SmartTab Drug Delivery Webinar

/PRNewswire/ -- SmartTab is a digital health startup and is continuing its healthtech innovation through patient-centered drug delivery with an upcoming...